Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Indian J Physiol Pharmacol ; 1995 Jul; 39(3): 271-4
Article in English | IMSEAR | ID: sea-107670

ABSTRACT

The activities of two enzymes viz: Na(+)-K(+)-ATPase and succinic dehydrogenase (SDH) in brain and liver of alloxan diabetic Swiss albino mice are reported. Alloxan diabetes caused significant decrease in the activity of Na(+)-K(+)-ATPase reflecting reduced glucose transport across the cell membrane. On the contrary, the observed enhanced activity of the enzyme SDH is attributed to increased supply of TCA cycle substrates from accelerated oxidation of fatty acids.


Subject(s)
Animals , Blood Glucose/metabolism , Brain/enzymology , Diabetes Mellitus, Experimental/enzymology , Female , Liver/enzymology , Liver Glycogen/metabolism , Male , Mice , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Succinate Dehydrogenase/metabolism
2.
Indian J Physiol Pharmacol ; 1993 Apr; 37(2): 151-4
Article in English | IMSEAR | ID: sea-108283

ABSTRACT

The present study reports in vitro inhibition of the activities of enzymes Na(+)-K(+)-ATPase and succinate dehydrogenase by alloxan in brain and liver homogenates of Swiss mice. The Vmax of both the enzymes was reduced in presence of alloxan without any substantial alteration in Km for substrate. Lineweaver Burk's plots showed higher 1/Vmax for alloxan treated samples and convergence of both slopes to intercept-1/Km. The observations pointed to non-competitive type inhibition of the enzymes by alloxan. This may be due to the modification of essential--SH groups present within/adjacent to substrate binding sites by alloxan.


Subject(s)
Alloxan/pharmacology , Animals , Brain/drug effects , Enzyme Inhibitors , Female , Kinetics , Liver/drug effects , Male , Mice , Sodium-Potassium-Exchanging ATPase/metabolism , Succinate Dehydrogenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL